Clinical Trials
729 trialsHypofractionated Radiation Therapy for Treating Prostate Cancer High-Risk Features Following Radical Prostatectomy
Mayo Clinic
CASCARA: Castration Sensitive Carboplatin, Cabazitaxel and Abiraterone
Masonic Cancer Center, University of Minnesota
PROSTATEP
University Hospital, Bordeaux
Nivolumab in Biochemically Recurrent dMMR Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Pertuzumab, Trastuzumab, Hyaluronidase-zzxf and Enzalutamide for Treatment of Metastatic Castration-Resistant Prostate Cancer
Mayo Clinic
UROPET
University Hospital, Bordeaux
Curcumin and Piperine in Patients on Surveillance for Monoclonal Gammopathy, Smoldering Myeloma or Prostate Cancer
University of Rochester
Study of 177Lu-PSMA-617 In Metastatic Castrate-Resistant Prostate Cancer in Japan
Novartis
Enhancing Readability of Lay Abstracts and Summaries for Medical Knowledge Using Generative Artificial Intelligence (BRIDGE AI 3)
University of Southern California
XmAb®20717 (Vudalimab) Alone or in Combination With Chemotherapy or Targeted Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer
Xencor, Inc.
Docetaxel and PROSTVAC for Metastatic Castration-Sensitive Prostate Cancer
National Institutes of Health Clinical Center (CC)
A Study of Stereotactic Body Radiation Therapy and Radium (Ra-223) Dichloride in Prostate Cancer That Has Spread to the Bones
Memorial Sloan Kettering Cancer Center
PICASSO
St Vincent's Hospital, Sydney
A Study of Apalutamide (Adjuvant Treatment) and Androgen Deprivation Therapy (ADT) in Participants Who Have Undergone Radical Prostatectomy (RP) for Non-metastatic Prostate Cancer and Who Are at High Risk for Metastases
Janssen Research & Development, LLC
CURIEFOCALE
Institut Claudius Regaud
Radium-223 in Combination With Enzalutamide
Cancer Trials Ireland
AASUR in High Risk Prostate Cancer
Memorial Sloan Kettering Cancer Center
Effects of Muscadine Grape Extract in Men With Prostate Cancer on Androgen Deprivation Therapy
Wake Forest University Health Sciences
High Resolution, 18F-PSMA PET-MRI Before Prostate Cancer HIFU or Radical Prostatectomy
Cedars-Sinai Medical Center
CKNO-PRO
Centre Oscar Lambret
Transrectal Tumour Oxygen - US Army
University Health Network, Toronto
TOPP
University Health Network, Toronto
Bullseye
Radboud University Medical Center
IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen
Janssen Biotech, Inc.
FOCALE
Hospices Civils de Lyon
Hypofractionated Adaptive Image-Guided Radiation Therapy for Localized Adenocarcinoma of the Prostate
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Fatigue Interventions in Cancer (Exercise Intervention)
University of Utah
OLIGOPELVIS
Institut Cancerologie de l'Ouest
CheckMate 9KD
Bristol-Myers Squibb
Abiraterone With Discontinuation of Gonadotropin-Releasing Hormone Analogues in Metastatic Prostate Cancer
Montefiore Medical Center
FOcal Radiation for Oligometastatic Castration-rEsistant Prostate Cancer (FORCE)
University of Michigan Rogel Cancer Center
Galahad
Janssen Research & Development, LLC
CheckMate 650
Bristol-Myers Squibb
RAVENS
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Pembrolizumab +/- SD-101 in Hormone-Naïve Oligometastatic Prostate Cancer With RT and iADT
University of California, San Francisco
CYTALUXâ„¢for the Intraoperative Imaging of Prostate Cancer
Indiana University
ARROW
Progenics Pharmaceuticals, Inc.
Improving Quality of Life of Prostate Cancer Survivors With Androgen Deficiency
Dana-Farber Cancer Institute
Safety and Efficacy of Oral Testosterone Undecanoate Followed by Enzalutamide as Therapy for Men With Metastatic Castrate Resistant Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
PANTHER
Duke University
A Study of Patients Receiving High-Dose Rate Brachytherapy
National Institutes of Health Clinical Center (CC)
OPTIMABI
Assistance Publique - Hôpitaux de Paris
IS-002 Phase 2 Prostate Cancer Study
Intuitive Surgical
Hypofractionation Proton Beam Therapy With Concurrent Treatment of Prostate and Pelvic Nodes for Prostate Cancer
Mayo Clinic
Gallium Ga 68-DOTATATE PET/CT in Diagnosing Patients With Metastatic Castration Resistant Prostate Cancer
Emory University
Using Multiparametric MRI to Evaluate Intraprostatic Tumor Responses and Androgen Resistance Patterns in Newly Diagnosed Prostate Cancer
National Institutes of Health Clinical Center (CC)
VitD/RNA-seq
Medical University of South Carolina
Darolutamide + Androgen Deprivation Therapy (ADT) in Chinese Men With High Risk, Nonmetastatic Prostate Cancer
Bayer
Combination Immunotherapy in Biochemically Recurrent Prostate Cancer
National Institutes of Health Clinical Center (CC)
Neoadjuvant And Adjuvant Abiraterone Acetate + Apalutamide Prostate Cancer Undergoing Prostatectomy
Dana-Farber Cancer Institute